Clinical Trials
4
Active:0
Completed:3
Trial Phases
3 Phases
Phase 1:1
Phase 3:2
Phase 4:1
Drug Approvals
78
TGA:78
Drug Approvals
OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial (446150)
- Product Name
- OCREVUS ocrelizumab 920 mg/23 mL solution for injection vial
- Approval Date
- Mar 27, 2025
TGA
ITOVEBI inavolisib 3 mg film-coated tablet blister pack (446750)
- Product Name
- ITOVEBI inavolisib 3 mg film-coated tablet blister pack
- Approval Date
- Mar 26, 2025
TGA
ITOVEBI inavolisib 9 mg film-coated tablet blister pack (446751)
- Product Name
- ITOVEBI inavolisib 9 mg film-coated tablet blister pack
- Approval Date
- Mar 26, 2025
TGA
VABYSMO faricimab 120 mg/mL solution for injection in a pre-filled syringe (449965)
- Product Name
- VABYSMO faricimab 120 mg/mL solution for injection in a pre-filled syringe
- Approval Date
- Sep 30, 2024
TGA
TECENTRIQ SC atezolizumab 1875 mg/15 mL solution for injection vial (400555)
- Product Name
- TECENTRIQ SC atezolizumab 1875 mg/15 mL solution for injection vial
- Approval Date
- Feb 29, 2024
TGA
COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial (392331)
- Product Name
- COLUMVI glofitamab (rch) 10 mg/10 mL concentrated solution for infusion vial
- Approval Date
- Aug 9, 2023
TGA
COLUMVI glofitamab (rch) 2.5 mg/2.5 mL concentrated solution for infusion vial (389650)
- Product Name
- COLUMVI glofitamab (rch) 2.5 mg/2.5 mL concentrated solution for infusion vial
- Approval Date
- Aug 9, 2023
TGA
XOFLUZA baloxavir marboxil 80 mg film-coated tablet blister pack (388092)
- Product Name
- XOFLUZA baloxavir marboxil 80 mg film-coated tablet blister pack
- Approval Date
- May 2, 2023
TGA
POLIVY polatuzumab vedotin 30 mg powder for injection vial (374135)
- Product Name
- POLIVY polatuzumab vedotin 30 mg powder for injection vial
- Approval Date
- Aug 10, 2022
TGA
VABYSMO faricimab 120 mg/mL solution for injection vial (369935)
- Product Name
- VABYSMO faricimab 120 mg/mL solution for injection vial
- Approval Date
- Aug 8, 2022
TGA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (50.0%)Phase 1
1 (25.0%)Phase 4
1 (25.0%)No trials found
News
Aga Khan University Hospital Launches Clinical Trial of KRAS Inhibitor GDC-6036 in Kenya
A new clinical trial in Kenya is evaluating Roche's GDC-6036, a novel drug targeting the KRAS gene, in cancer patients.
ICH E6(R3) Guidelines Set to Transform Clinical Trial Quality Management in 2025
The International Council for Harmonisation (ICH) has released draft E6(R3) guidelines aimed at modernizing Good Clinical Practice standards, with final implementation expected in 2025.